Trending...
- Eric Bohannon Joins Buoy Health Board of Directors
- Knobull Helps Followers Make The Most Of Small Living Space
- Procurement Partners Welcomes Troy Thibodeau as Chief Marketing Officer
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the three months ended March 31, 2022 on May 11, 2022 after the market close.
The Company will host a conference call the same day, Wednesday, May 11, 2022 at 4:30 p.m. ET with prepared remarks by Paul R. Gudonis, chairman and chief executive officer, and David Henry, chief financial officer.
Participants are encouraged to pre-register for the conference call using this link. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those without internet access or unable to pre-register may dial in by calling, 1-844-707-6932 (U.S.) or 1-412-317-9250 (International). A webcast of the call may also be accessed at Myomo's Investor Relations page at http://ir.myomo.com/.
More on Boston Chron
A replay of the webcast will be available beginning approximately one hour after the completion of the live conference call at http://ir.myomo.com/. A dial-in replay of the call will be available until May 25, 2022; please dial 1-877-344-7529 (U.S.) or 1-412-317-0088 (International) and provide the access code # 6293427.
About Myomo, Inc.
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. It is currently the only marketed device that, sensing a patient's own EMG signals through non-invasive sensors on the arm, can restore an individual's ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Boston, Massachusetts, with sales and clinical professionals across the U.S and representatives internationally. For more information, please visit www.myomo.com.
More on Boston Chron
Contacts
For Myomo:
ir@myomo.com
Investor Relations:
Kim Sutton Golodetz
LHA Investor Relations
212-838-3777
kgolodetz@lhai.com
The Company will host a conference call the same day, Wednesday, May 11, 2022 at 4:30 p.m. ET with prepared remarks by Paul R. Gudonis, chairman and chief executive officer, and David Henry, chief financial officer.
Participants are encouraged to pre-register for the conference call using this link. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those without internet access or unable to pre-register may dial in by calling, 1-844-707-6932 (U.S.) or 1-412-317-9250 (International). A webcast of the call may also be accessed at Myomo's Investor Relations page at http://ir.myomo.com/.
More on Boston Chron
- The City Celebrates the Grand Opening of Barnard Place Park in South Boston
- InsideTracker Celebrates Global Running Day with Live, Virtual Event Featuring Rahaf Khatib, Sally McRae
- Starry Group Holdings, Inc. to Present at UBS Future of 5G Conference
- DOUG RENDE HAS BEEN SELECTED TO LEAD NORTH AMERICAN SPECIALTY LAMINATIONS, THE NORTH AMERICAN LEADER IN DIFFERENTIATED LAMINATED SOLUTIONS TO THE BUILDING MATERIALS INDUSTRY.
- Fantastic Sams Franchise Corporation Partners with First Development Agent in the Brand's Ambitious Expansion Initiative
A replay of the webcast will be available beginning approximately one hour after the completion of the live conference call at http://ir.myomo.com/. A dial-in replay of the call will be available until May 25, 2022; please dial 1-877-344-7529 (U.S.) or 1-412-317-0088 (International) and provide the access code # 6293427.
About Myomo, Inc.
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. It is currently the only marketed device that, sensing a patient's own EMG signals through non-invasive sensors on the arm, can restore an individual's ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Boston, Massachusetts, with sales and clinical professionals across the U.S and representatives internationally. For more information, please visit www.myomo.com.
More on Boston Chron
- Alkermes Announces Continued Board Refreshment, Including the Appointment of Christopher I. Wright, M.D., Ph.D. to its Board of Directors
- Brian Peterson assisted Kaplan Tarps & Cargo Controls with obtaining a GSA Multiple Award Schedule
- Waters Corporation Presentation at the Jefferies 2022 Global Health Care Conference
- Boston: Mayor Wu Announces Curbside Food Waste Collection Program
- New Bill Opens the Door for Lawsuits Against the Government Based on Contaminated Drinking Water at Camp Lejeune
Contacts
For Myomo:
ir@myomo.com
Investor Relations:
Kim Sutton Golodetz
LHA Investor Relations
212-838-3777
kgolodetz@lhai.com
Filed Under: Business
0 Comments
Latest on Boston Chron
- Up and coming POP / R&B Girl Group Releases New Music Video
- Boston: Mayor Wu Provides Updates on City Efforts to Address Unsheltered Homelessness and Substance Use Crises Centered at Massachusetts Avenue and Melnea Cass Boulevard
- Schneider Electric Ranked Energy as a Service Leader by Guidehouse Insights
- Industrial IoT edge is now creating savings and opening the door to new revenue sources for enterprises
- Black Bourbon Society Partners With Jim Beam® for the 2nd Annual Open Door Tour
- IDpack in the Cloud, the official service provider for the 2022 Memorial Cup presented by Kia
- Hologic Announces European CE Mark for Molecular Assays for Use with Transplant Patients
- Eric Bohannon Joins Buoy Health Board of Directors
- ASI Launches iMIS.com Product Website, Expands Resources for Associations & Non-Profits
- Strategy Analytics: US Self-monitored Security Market to Reach $5.3B in 2027
- Suzahdi on eBay Australia in Warm Winter Leather 2022
- Paddle acquires ProfitWell to automate payments infrastructure for SaaS companies
- Stratum Nutrition® Announces Market Ready Dairy Free BLIS K12® and BLIS M18®
- CORRECTING and REPLACING Press Ganey, KidsX to Launch Pediatric Healthcare Accelerator to Address Health Issues in Lives of Children
- MC Residential LLC Names Greg Flatt Regional Vice President
- ENERGY33 is awarded an Engineering & Construction Management Contract in Honduras
- Join us Memorial Day Weekend - Sunday Brunch in Astoria, Queens
- Eastern Bank Foundation Honors CommonWealth Kitchen With A Community Advocacy Award
- Latino Leaders Network to Honor Mayor Tim Keller of Albuquerque with Antonio Villaraigosa Leadership Award at the 36th Tribute to Mayors
- Procurement Partners Welcomes Troy Thibodeau as Chief Marketing Officer